Aperio Group’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.15M Buy
20,639
+118
+0.6% +$6.09K ﹤0.01% 1524
2020
Q3
$893K Buy
20,521
+470
+2% +$21.2K ﹤0.01% 1494
2020
Q2
$915K Buy
20,051
+1,034
+5% +$41.7K ﹤0.01% 1456
2020
Q1
$594K Sell
19,017
-175
-0.9% -$6.23K ﹤0.01% 1562
2019
Q4
$599K Buy
19,192
+5,035
+36% +$144K ﹤0.01% 1707
2019
Q3
$431K Buy
14,157
+2,515
+22% +$102K ﹤0.01% 1845
2019
Q2
$693K Buy
11,642
+791
+7% +$45.4K ﹤0.01% 1601
2019
Q1
$671K Sell
10,851
-2,931
-21% -$166K ﹤0.01% 1575
2018
Q4
$769K Buy
13,782
+2,318
+20% +$138K ﹤0.01% 1445
2018
Q3
$704K Buy
11,464
+185
+2% +$10.6K ﹤0.01% 1590
2018
Q2
$577K Buy
11,279
+798
+8% +$39.5K ﹤0.01% 1684
2018
Q1
$475K Buy
10,481
+258
+3% +$11.7K ﹤0.01% 1714
2017
Q4
$442K Buy
10,223
+70
+0.7% +$2.94K ﹤0.01% 1753
2017
Q3
$430K Sell
10,153
-314
-3% -$12.7K ﹤0.01% 1734
2017
Q2
$399K Buy
10,467
+391
+4% +$13.1K ﹤0.01% 1755
2017
Q1
$291K Buy
10,076
+44
+0.4% +$1.23K ﹤0.01% 1839
2016
Q4
$266K Buy
10,032
+326
+3% +$7.87K ﹤0.01% 1847
2016
Q3
$236K Buy
+9,706
New +$224K ﹤0.01% 1856

Other funds holding MMSI

Aperio Group's MMSI Position: Q4 2020 in Review

Aperio Group increased its Merit Medical Systems (MMSI) stake by 0.58% in Q4 2020, buying an estimated $6.09K and bringing the position to 20,639 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Aperio Group first reported a position in MMSI in Q3 2016 and has held it in 18 quarters since. 226 funds tracked by Wall St. Rank hold MMSI as of Q4 2020.

  • Aperio Group held 20,639 shares of Merit Medical Systems worth $1.15M as of Q4 2020.
  • Aperio Group bought 118 Merit Medical Systems shares in Q4 2020, an estimated $6.09K.
  • Merit Medical Systems made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1524 holding.
  • Aperio Group first reported a position in Merit Medical Systems in Q3 2016 and has held it in 18 quarters since.
  • 226 funds tracked by Wall St. Rank held Merit Medical Systems as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.